MDS

OTTAWA, Canada and FLEURUS, Belgium - Site to Provide Fluorodeoxyglucose (F-18 FDG) for use in Earlier Detection of Disease and Therapy Management MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular medicine, today announced the opening of a facility in Fleurus, Belgium for the production of Fluorodeoxyglucose (F-18 FDG), a radiopharmaceutical used in positron emission tomography (PET) imaging.